• Marinus Pharmaceuticals (NASDAQ:MRNS) Downgraded by Zacks Investment Research to Hold

    Zacks Investment Research lowered shares of Marinus Pharmaceuticals (NASDAQ:MRNS) from a buy rating to a hold rating in a research report sent …

    Read More
  • 0 0